Effects of Unsupervised Inspiratory Muscle Training on Ventilation Variability in Post-covid-19 Patients. - Trial NCT06362499
Access comprehensive clinical trial information for NCT06362499 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidade Federal do Rio Grande do Norte and is currently Recruiting. The study focuses on COVID-19. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Universidade Federal do Rio Grande do Norte
Timeline & Enrollment
N/A
Apr 01, 2024
Jul 31, 2024
Primary Outcome
Ventilation variability and ventilation efficiency
Summary
Dysfunctional breathing and persistent hypocapnia can be associated with many of the symptoms
 experienced by patients such as dyspnea, fatigue, chest pain and palpitations. The
 identification of dysfunctional breathing and hypocapnia in these patients is important as it
 may represent a target for treatment.
 
 In many of these patients, tachypnea at low levels of exertion suggests increased respiratory
 muscle activity, which can lead to the sensation of dyspnea. Sympathetic hyperactivity leads
 to excessive and irregular ventilation during exercise. In this way, inspiratory muscle
 training can improve symptoms (dysfunctional breathing), possibly by attenuating the
 metaboreflex (vagal modulation-attenuation of the sympathetic response) of the inspiratory
 muscle in post-covid-19 subjects, reducing ventilatory variability.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06362499
Device Trial